Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linaprazan Glurate vs Lansoprazole in Erosive Esophagitis
NCT07037875Phase 3Completed
- Sponsor
- Cinclus Pharma
- Start
- Sep 2025
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of linaprazan glurate in erosive esophagitis (EE), gastroesophageal reflux disease (GERD), sponsored by Cinclus Pharma. Started Sep 2025; status: completed.
02
Drugs
linaprazan glurate
03
Conditions
erosive esophagitis (EE)gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT07037875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07037875.